ClinicalTrials.Veeva

Menu

The Effect of Glaucoma Drops on of the Duration of a Pure Intraocular Gas Bubble

J

Jason Hsu, MD

Status

Completed

Conditions

Scleral Buckling

Treatments

Drug: standard post-operative topical drops
Drug: Timolol-dorzolamide (Glaucoma drops)

Study type

Interventional

Funder types

Other

Identifiers

NCT01843920
11095 Gas Duration
11-095

Details and patient eligibility

About

A controlled clinical study comparing the effect of topical aqueous suppressants on intraocular gas duration.

Full description

A Prospective, Randomized Study Comparing the Effects of Topical Aqueous Suppressants on Intraocular Gas Duration following Scleral Buckling and Pneumatic Retinopexy

Enrollment

21 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Ability to provide written informed consent and comply with study assessments for the full duration of the study.
  • Have undergone eye surgery including scleral buckling or pneumatic retinopexy for treatment of retinal detachment other condition at the discretion of the investigator.

Exclusion criteria

  • Prior surgery to treat glaucoma.
  • Current use of glaucoma eye drops.
  • Absence of a lens in the eye or presence of a lens implant in front of the iris (colored part of your eye).
  • Allergy or contraindication to any of the glaucoma drops being used in this study (e.g., sulfa allergy, asthma, chronic obstructive pulmonary disease (bronchitis or emphysema), slow heart rate).

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

21 participants in 2 patient groups

Post surgery without glaucoma drops
Active Comparator group
Description:
This will be for the group that had gas duration surgery using SF6 (Sulfur Hexafluoride) or C3F8 (perfluoropropane gas tamponade) and only uses the standard post-operative topical drops.
Treatment:
Drug: standard post-operative topical drops
Post surgery with glaucoma drops
Experimental group
Description:
This will be for the group that had gas duration surgery (using SF6 or C3F8). In addition to the standard post-operative topical drops, glaucoma drops, Timolol-dorzolamide (timolol 0.5%-dorzolamide 2%) will be given.
Treatment:
Drug: Timolol-dorzolamide (Glaucoma drops)
Drug: standard post-operative topical drops

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems